Coupling of D1 and D5 dopamine receptors to multiple G proteins: Implications for understanding the diversity in receptor-G protein coupling

Molecular Neurobiology

Volumn 16, Issue 2, 1998, Pages 125-134

  Sidhu, Anita ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine receptors; G proteins; Signal transduction

Indexed keywords

DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; DRD5 PROTEIN, HUMAN;

ARTICLE; BINDING COMPETITION; HORMONE RECEPTOR INTERACTION; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D5;

EID: 0031593667     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02740640     Document Type: Article

References (51)

1. q/11. J. Biol. Chem. 269, 13,733-13,735.
2. Bergson C., Mrzljak L., Smiley J. F., Pappy M., Levenson R., and Goldman-Rakic P. S. (1995a) Regional, cellular and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J. Neurosci. 15, 7821-7836.
3. Bergson C., Mrzljak L., Lidow M. S., Goldman-Rakic P. S., and Levenson R. (1995b) Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc. Natl. Acad. Sci. USA 92, 3468-3472.
4. Bertorello A. and Aperia A. (1988) Pertussis toxin modulates dopamine inhibition of Na,K-ATPase activity in rat proximal convoluted tubule segments. Prog. Clin. Biol. Res. 268B, 353-356.
5. +-ATPase activity in neostriatal neurons through D1 and D2 receptor synergism. Nature (Lond.) 347, 386-388.
6. Birnbaumer L., Abramowitz J., and Brown A. M. (1990) Receptor-effector coupling by G proteins. Biochim. Biophys. Acta. 1031, 163-224.
7. Choi W. S., Machida C. A., and Ronnekleiv O. K. (1995) Distribution of D1, D2 and D5 receptor mRNA in the monkey brain: ribonulease protection assay analysis. Brain Res. Mol. Brain Res. 31, 86-94.
8. Cooper D. M. F., Mons N. and Karpen J. W. (1995) Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374, 421-424.
9. Dahmer M. K. and Senogles S. E. (1996) Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. J. Neurochem. 66, 222-232.
10. Demchyshyn L. L., Sugamori K. S., Lee F. J. S., Hamadanizadeh S. A., and Niznik H. B. (1995) The dopamine DID receptor: cloning and characteristics of three pharmacologically distinct D-1-like receptors from Gallus domesticus. J. Biol. Chem. 270, 4005-4012.
11. Exton J. H. (1994) Phosphoinositide phospholipases and G proteins in hormone action. Ann. Rev. Physiol. 56, 349-369.
12. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am. J. Physiol. 259, F297-F303.
13. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
14. Glatt C. E. and Snyder S. H. (1993) Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361, 536-538.
15. Grandy, D. K., Zhang Y., Bouvier C., Zhou Q-Y., Johnson R. A., Allen L., Buck K., Bunzow J. R., Salon J. and Civelli O. (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. USA 88, 9175-9179.
16. Hepler J. R. and Gilman A. G. (1992) G proteins. Trends Biochem. Sci. 17, 383-387.
17. Hill P., Lai Y., Hnilo J., Lin C. -C., Karla M., Bounds S., Herz J., and Mitchell R. (1996) Cloning, expression and comparison of the binding characteristics of the known human dopamine receptors. Adv. Neurol. 69, 41-52.
18. Hille B. (1994) Modulation of ion-channel function by G-protein-coupled receptors. Trends Neurosci. 17, 531-536.
19. z in rat liver. J. Biol. Chem. 269, 1845-1851.
20. Kimura K., Sela S., Bouvier C., Grandy D. K., and Sidhu A. (1995a) Differences in the binding properties of D-1 and D-5 dopamine receptors expressed in GH4C1 rat somatomammotrophic cells. J. Neurochem. 64, 2118-2124.
21. o. J. Biol. Chem. 270, 14,672-14,678.
22. Kitai S. T. and Surmeier D. J. (1993) Cholinergic and dopaminergic modulation of potassium conductances in neostriatal neurons. Adv. Neurol. 60, 40-52.
23. zα. J. Biol. Chem. 270, 1734-1741.
24. 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30, 3335-3341.
25. + efflux in the chick retina via D1 receptors independently of adenylyl cyclase activation. J. Neurochem. 61, 1461-1469.
26. Law S. F., Manning D. R., and Reisine T. (1991) Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J. Biol. Chem. 266, 17,885-17,897.
27. zα by site-directed mutagenesis: Sites and specificity of protein kinase C-dependent phosphorylation. J. Biol. Chem. 268, 3494-3498.
28. 2+ mobilization in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87, 2196-2200.
29. Milligan G. (1993) Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14, 239-244.
30. Nash S. R., Godinot N., and Caron M. G. (1993) Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Mol. Pharmacol. 44, 918-925.
31. Neer E. J. (1994) G proteins: critical control points for transmembrane signals. Protein Sci. 3, 3-14.
32. O'Dowd B. F. (1993) Structures of dopamine receptors. J. Neurochem. 60, 804-816.
33. i1, leading to the inhibition of adenylate cyclase in transfected cell lines. J. Pharmacol. Expt. Ther. 278, 354-360.
34. 2a-adrenergic receptor-GTP-binding complexes using GTP-binding protein selective antisera. J. Biol. Chem. 267, 14,826-14,831.
35. Paulssen R. H., Johansen P. W., Gordeladze J. O., Nymoen O., Paulssen E. J., and Gautvik K. M. (1994) Cell-specific expression and function of adenylyl cyclases in rat pituitary tumor cell lines. Eur. J. Pharmacol. 222, 97-103.
36. Piomelli D., Pilon C., Giros B., Sokoloff P., Martes M.-P., and Schwartz, J.-C. (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1\D2 receptor synergism. Nature 353, 164-167.
37. Schneider H., Feyen J. H., and Suewen K. (1994) A C-terminally truncated human parathyroid hormone receptor is functional and activites multiple G proteins. FEBS Lett. 351, 281-285.
38. Sidhu A. (1997) Regulation and expression of D-1, but not D-5, dopamine receptors in human SK-N-MC neuroblastoma cells. J. Recep. Res/Sig. Trans. 17, 777-784.
39. Sidhu A. and Fishman P. H. (1990) Identification and characterization of functional D1 dopamine receptors in a human neuroblastoma cell line. Biocheni. Biophys. Res. Commun. 166, 574-579.
40. Sidhu A. and Kebabian J. W. (1985) An iodinated ligand identifying the D-1 dopamine receptor. Eur. J. Pharmacol. 113, 437-440.
41. Sidhu A., Kassis S., Kebabian J., and Fishman P. H. (1986) Sulphydryl group(s) in the ligand binding sites of the D-1 dopamine receptor: specific protection by agonist and antagonist. Biochemistry 25, 6695-6701.
42. Sidhu A., Banta M., Uh M., and Shin Y. -M. (1998a) Comparative analyses of photoaffinity labeling of D-1 and D-5 dopamine receptors. Neuroscience 82, 1095-1101.
43. z. J. Neurochem. (in press).
44. Sidhu A., Sullivan M., Kohout T., Balen P., and Fishman, P. (1991) D1 dopamine receptors can interact with both stimulatory and inhibitory guanine nucleotide binding proteins. J. Neurochem. 57, 1445-1451.
45. Smrcka A. V., Hepler J. R., Brown K. O., and Sternweis P. C. (1991) Regulation of polyphospho-inositide-specific phospholipase C activity by purified Gq. Science 251, 804-807.
46. 1C dopamine receptors from Xenopus laevis. Proc. Natl. Acad. Sci. USA 91, 10,536-10,540.
47. Sunahara R. K., Guan H. -C., O'Dowd B. F., Seeman, P., Laurier L. G., Ng G., George S. R., Torchia J., Van Tol H. H. M., and Niznik H. B. (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350, 614-619.
48. Undie A. S., Weinstock J., Sarua H. M., and Friedman E. (1994) Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62, 2045-2048.
49. Wong S. K.-F., Parker E. M., and Ross E. M. (1990) Chimeric cholinergic: β-adrenergic receptors that activate Gs in response to muscarinic agonists. J. Biol. Chem. 265, 6219-6224.
50. z-mediated hormonal inhibition of cyclic AMP accumulation. Science 255, 339-342.
51. Yoshimura M., Ikeda H., and Tabakoff B. (1996) Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase and enhance dopamine-stimulated activity of type VII adenylyl cyclase. Mol. Pharmacol. 50, 43-51.